A report on the experiences of 13 patients found that the drug had no benefit for some and that some who benefited said the ...

A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating symptoms. Research shows extended Paxlovid treatment could help restore ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...

A study indicates that longer Paxlovid treatments could improve long COVID symptoms in some patients, highlighting the need ...

The findings run counter to a clinical trial which found no benefit from Paxlovid in long COVID patients WEDNESDAY, Jan. 8, ...

An up-close look at how patients respond to the drug at different times and doses adds nuance to a recent finding that ...

Extended courses of Paxlovid may alleviate symptoms in some patients with long Covid, though its effectiveness varies widely.

A detailed examination of how patients respond to the drug at various times and doses provides greater context to a recent ...

By Pam Belluck Pam Belluck has covered long Covid since the condition first emerged. Can Paxlovid treat long Covid? A new report suggests it might help some patients, but which patients might ...

A recent patient-led case series highlights the potential benefits of extended courses of Pfizer Inc's (NYSE:PFE) Paxlovid ...

An extended course of Paxlovid appears to help some patients with long Covid, according to research that suggests this treatment option holds promise for some of those struggling with debilitating ...